Skip to main content
HealthReportedLow
2.0

Novo Nordisk launches Wegovy in Costa Rica for chronic weight management

Novo Nordisk's Wegovy (semaglutide) is now available in Costa Rica, expanding access to the GLP-1 weight-loss drug in Central America. The launch follows regional approvals and reflects growing demand for obesity treatments, though pricing and coverage details remain unclear.

La Nación (Costa Rica)3 days agoCR, USCredibility 17%View source

Score Breakdown

Mosaic Score2.0
Model confidence0.5
Significance0.1
Source credibility0.2

Intelligence Tags

Locations

Costa Rica

Entities

country
Source

Related signals

8 found